22:45 , Nov 30, 2017 |  BC Extra  |  Company News

Management Tracks:Sunesis, City of Hope

Cancer company Sunesis Pharmaceuticals Inc. (NASDAQ:SNSS) hired William Quinn as CFO and SVP of finance and corporate development. He was president and CEO of Bullet Biotechnology Inc. (Redwood City, Calif.), which he co-founded. City of...
07:00 , Mar 24, 2014 |  BioCentury  |  Emerging Company Profile

Bullet: Idiotype builder

Bullet Biotechnology Inc. is using new sequencing and manufacturing methods to develop an idiotype cancer vaccine that it anticipates will be more effective than first-generation products. President and CEO Willie Quinn said the first wave...
07:00 , Sep 30, 2013 |  BC Week In Review  |  Clinical News

Bullet Biotechnology preclinical data

In a mouse model of lymphoma, BB-001 significantly improved event-free survival (EFS) vs. controls vaccinated with an idiotype protein coupled to keyhole limpet hemocyanin carrier protein (KLH). Bullet said it has prioritized development of BB-001...
07:00 , Sep 16, 2013 |  BC Week In Review  |  Financial News

Bullet Biotechnology completes venture financing

Bullet Biotechnology Inc. , Menlo Park, Calif.   Business: Cancer   Date completed: 6/1/13   Type: Venture financing   Raised: $2.5 million   Note: On Sept. 12, Bullet Biotechnology said it completed the offering in...
07:00 , Jul 29, 2013 |  BC Week In Review  |  Financial News

Bullet Biotechnology completes venture financing

Bullet Biotechnology Inc. , Menlo Park, Calif.   Business: Cancer   Date completed: 7/9/13   Type: Venture financing   Raised: $1.1 million   Note: According to an SEC filing, Bullet Biotechnology raised $1.1 million in...